Exclusive: EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccines

By Francesco Guarascio BRUSSELS (Reuters) - The European Union is negotiating advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna , Sanofi and Johnson & Johnson as well as biotech firms BioNtech and CureVac, two EU sources told Reuters. The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential COVID-19 vaccine, in principle available to all 27 EU nations. The information on the ongoing talks was shared by the European Commission, the EU executive arm, with EU health ministers at a meeting in Berlin on Thursday, the sources said.

Reuters July 18, 2020 01:05:41 IST
Exclusive: EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccines

Exclusive EU in talks with Moderna BioNtech CureVac to secure possible COVID vaccines

By Francesco Guarascio

BRUSSELS (Reuters) - The European Union is negotiating advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna , Sanofi and Johnson & Johnson as well as biotech firms BioNtech and CureVac, two EU sources told Reuters.

The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential COVID-19 vaccine, in principle available to all 27 EU nations.

The information on the ongoing talks was shared by the European Commission, the EU executive arm, with EU health ministers at a meeting in Berlin on Thursday, the sources said.

The multiple talks confirm the bloc's more assertive stance on procuring potential COVID-19 shots and drugs after early U.S. moves in securing promising treatments and vaccines.

"We are in talk with several companies on possible COVID-19 vaccines," a spokesman for the Commission said on Friday, declining to comment on specific firms as negotiations were confidential.

More than 150 possible vaccines are being developed and tested around the world to try to stop the pandemic. Of 23 in human clinical trials, at least three are in final Phase III testing - including candidates from China's Sinopharm and Sinovac Biotech and AstraZeneca and Oxford University.

The most advanced EU talks appear to be those with Johnson & Johnson and Sanofi, confirming a Reuters report in June, because the EU is already discussing details on the number of doses needed.

With U.S. giant Johnson & Johnson, the EU is negotiating a supply of 200 million doses of its possible vaccine, the sources said, adding that additional supplies may also be available.

'ADVANCED TALKS'

The bloc is also planning to secure in the second half of next year 300 million doses of the potential vaccine developed by France's Sanofi in cooperation with British drugmaker GlaxoSmithKline Plc , the sources said.

Asked about the negotiations, Sanofi told Reuters it was in "advanced talks with the EU for the delivery of 300 million doses".

Negotiations were also ongoing, sources said, with U.S. firm Moderna, whose experimental COVID-19 vaccine showed this week that it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, according to U.S. researchers.

Later on Friday Moderna confirmed it was in talks with European countries on its potential vaccine, but said at this stage it had no agreement to announce.

The EU is also in talks with German biotechnology firms BioNtech and CureVac to buy in advance their potential vaccines, the sources said. Both firms, which have already been offered EU funds to develop their shots, declined to comment.

BioNtech is developing a potential COVID-19 vaccine in cooperation with U.S. pharmaceutical giant Pfizer , for which 100 million doses could be available by the end of the year.

CureVac is a pioneer in the so-called messenger RNA approach, which is also being pursued by BioNTech and Moderna.

RNA molecules are single-stranded versions of the DNA double-helix that can be produced in a relatively simple biochemical process.

The EU-led talks are conducted by negotiators selected by a steering group in which all 27 EU states are represented.

Once deals are struck, EU states can place orders with drugmakers to secure precise amounts for their populations.

If doses of successful vaccines were not sufficient to cover the whole EU population, shots would be distributed based on demographic and epidemiological data, the Commission has repeatedly said.

A third EU source said the bloc was also renegotiating the deal struck with AstraZeneca by Germany, France, Italy and the Netherlands, to make sure all EU states had equal access to the doses secured in the initial deal.

The source said this discussion was backed by the four states which first signed the deal.

(Reporting by Francesco Guarascio with additional reporting by Matthias Blamont in Paris, Caroline Copley in Berlin, Kate Kelland in London and Julie Steenhuysen; editing by Nick Macfie/Mark Heinrich)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

France, Germany to agree to NATO role against Islamic State - sources
| Reuters
World

France, Germany to agree to NATO role against Islamic State - sources | Reuters

By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States

China's Xi says navy should become world class
| Reuters
World

China's Xi says navy should become world class | Reuters

BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.